Wuhan YZY Biopharma Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	100.07	126.28	196.68	153.52	83.09
Trading Asset Securities	-	-	-	15	2.5
Cash & Short-Term Investments	100.07	126.28	196.68	168.52	85.59
Cash Growth	-20.76%	-35.80%	16.71%	96.90%	-
Accounts Receivable	25.55	51.11	-	-	-
Other Receivables	3	6.83	16.03	0.66	-
Receivables	28.55	57.94	16.03	0.66	-
Inventory	3.29	4.26	5.77	10.62	8.91
Other Current Assets	-	32.86	31.62	59.16	31.14
Total Current Assets	131.9	221.34	250.1	238.96	125.64
Property, Plant & Equipment	42.04	45.41	50.38	54.55	59.96
Other Long-Term Assets	1.07	1.09	1.14	9.34	14.55
Total Assets	175.01	267.84	301.62	302.84	200.16
Accounts Payable	45.06	0.14	0.19	0.08	4.85
Accrued Expenses	-	45.17	37.95	22.17	16.03
Short-Term Debt	-	-	-	76.5	28
Current Portion of Long-Term Debt	100.01	75.82	89.5	-	-
Current Portion of Leases	0.25	0.36	0.46	0.17	0.4
Current Income Taxes Payable	-	0.47	0.5	0.45	0.36
Current Unearned Revenue	15.72	21.08	0.64	3.85	1.45
Other Current Liabilities	39.5	43.1	44.58	43.74	5.82
Total Current Liabilities	200.54	186.14	173.82	146.96	56.91
Long-Term Debt	27.5	51.08	-	-	-
Long-Term Leases	-	0.09	0.15	-	0.08
Total Liabilities	228.04	237.31	173.97	146.96	56.99
Common Stock	193.85	193.85	193.85	182	-
Additional Paid-In Capital	-	345.01	345.01	193.38	613.6
Retained Earnings	-	-510.39	-412.79	-221.09	-572.44
Comprehensive Income & Other	-246.88	2.06	1.58	1.58	102
Shareholders' Equity	-53.03	30.54	127.65	155.88	143.16
Total Liabilities & Equity	175.01	267.84	301.62	302.84	200.16
Total Debt	127.76	127.35	90.11	76.67	28.48
Net Cash (Debt)	-27.69	-1.08	106.57	91.85	57.11
Net Cash Growth	-	-	16.02%	60.85%	-
Net Cash Per Share	-0.14	-0.01	0.58	0.53	0.38
Filing Date Shares Outstanding	191.3	193.85	193.85	182	152.11
Total Common Shares Outstanding	191.3	193.85	193.85	182	152.11
Working Capital	-68.64	35.2	76.28	92	68.73
Book Value Per Share	-0.28	0.16	0.66	0.86	0.94
Tangible Book Value	-53.03	30.54	127.65	155.88	143.16
Tangible Book Value Per Share	-0.28	0.16	0.66	0.86	0.94
Buildings	-	15.4	15.04	15.04	15.04
Machinery	-	68.16	68.33	66.81	65.46
Construction In Progress	-	16.85	16.85	16.85	16.85
Leasehold Improvements	-	1.76	1.76	1.76	1.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.